Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Shares Outstanding (Weighted Average) (2016 - 2018)

Armata Pharmaceuticals' Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $4.7 million for Q3 2018.

  • For Q3 2018, Shares Outstanding (Weighted Average) fell 47.57% year-over-year to $4.7 million; the TTM value through Sep 2018 reached $4.7 million, down 47.57%, while the annual FY2017 figure was $6.4 million, 549.23% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2018 was $4.7 million at Armata Pharmaceuticals, roughly flat from $4.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $182.5 million in Q1 2014 and bottomed at $588350.0 in Q1 2016.
  • The 5-year median for Shares Outstanding (Weighted Average) is $4.0 million (2014), against an average of $14.2 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) crashed 97.67% in 2015 before it soared 698.07% in 2017.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $3.7 million in 2014, then skyrocketed by 40.06% to $5.2 million in 2015, then crashed by 81.25% to $983846.0 in 2016, then surged by 549.23% to $6.4 million in 2017, then fell by 27.16% to $4.7 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Shares Outstanding (Weighted Average) are $4.7 million (Q3 2018), $4.7 million (Q2 2018), and $13.3 million (Q1 2018).